Quick answer
Colorectal cancer treatment in China costs $12,000–$20,000 for surgery and $25,000–$50,000 for a full course — against $60,000–$100,000 and $120,000–$200,000 in the US. The plan turns on where the tumour sits, not only on the stage: colon cancer is usually operated on first, while locally advanced rectal cancer commonly receives chemotherapy and radiotherapy before surgery. Whether the anal sphincter can be preserved depends on tumour height, how the tumour responded to chemoradiotherapy and your pelvic anatomy, and very low tumours may need an abdominoperineal resection with a permanent stoma. Molecular testing decides the drugs: MMR/MSI status determines whether immunotherapy applies, and RAS/BRAF testing determines whether an anti-EGFR agent such as cetuximab is worth using. The Cancer Hospital of CAMS in Beijing is recorded in our directory as first in oncology nationally, with Sun Yat-sen University Cancer Center and Fudan University Shanghai Cancer Center in the national top three.
Who this is for
Typically a good fit if
- Your diagnosis is confirmed by colonoscopy with biopsy, and staging by CT of the chest, abdomen and pelvis is available
- For a rectal tumour, you have had a pelvic MRI — that scan is what determines whether the sphincter can be preserved
- Molecular testing for MMR/MSI and RAS/BRAF has been done, because it decides whether targeted or immunotherapy drugs apply to you
- You have locally advanced rectal cancer being considered for chemoradiotherapy before surgery
- You can stay for the course — about a week in hospital for a colectomy, or five to six weeks if your plan starts with chemoradiotherapy
May not be suitable if
- You want a guarantee that the sphincter will be saved — it is the question patients care about most and the one least answerable in advance
- You would treat a stoma as a failure — for a very low rectal tumour, an abdominoperineal resection with a permanent colostomy can be the operation that offers a cure
- You want a fixed price before the tumour site is reviewed — colon and rectal treatment differ, and the drug regimen is the largest single variable
- You expect an anti-EGFR agent regardless of your tumour — cetuximab only helps RAS wild-type tumours, which is why RAS is tested first
- You expect immunotherapy regardless of your tumour — it applies to MSI-high or dMMR disease, which MMR/MSI testing determines
Diagnosis
Diagnosis uses colonoscopy with biopsy, staging by CT of the chest, abdomen and pelvis, pelvic MRI for rectal tumours, and PET-CT when indicated. Molecular testing covers MMR/MSI status and RAS/BRAF mutations, which guide targeted and immunotherapy decisions.
Treatment Options
Treatment depends on the site and stage. Colon cancer is usually treated with colectomy; rectal cancer commonly receives neoadjuvant chemoradiotherapy before surgery. Very low tumours may need abdominoperineal resection with a permanent stoma, while sphincter-preserving resection is possible in selected cases. Systemic options include FOLFOX or FOLFIRI chemotherapy, anti-EGFR agents such as cetuximab for RAS wild-type tumours, bevacizumab, and immunotherapy for MSI-high or dMMR disease.
What the Treatment Involves
- Records review and staging confirmationBefore travelSend your pathology, staging CT and — for a rectal tumour — pelvic MRI, plus your molecular results. The centre confirms the stage and whether the plan starts with surgery or with chemoradiotherapy.
- Treatment plan and written quote2–4 weeksA written plan and cost estimate, once the tumour site and stage are established. Colon and rectal treatment differ enough that the plan comes first and the price follows.
- Arrival and evaluationDays 1–3Physical examination, any updated imaging, and a multidisciplinary team (MDT) consultation that confirms the plan.
- Neoadjuvant chemoradiotherapy, where plannedAbout 5–6 weeksFor locally advanced rectal cancer, chemotherapy with radiotherapy is given before surgery to shrink the tumour, which makes a sphincter-preserving operation more often achievable.
- SurgeryScheduled after the pre-operative phaseColectomy with the bowel rejoined for colon cancer, increasingly performed laparoscopically. For rectal cancer, sphincter-preserving resection where the margins allow, or abdominoperineal resection with a permanent stoma for very low tumours.
- Adjuvant chemotherapy and follow-upCycles every 2–3 weeks, then ongoingFOLFOX or FOLFIRI, with bevacizumab a common addition. A treatment summary goes to your home oncologist, with remote follow-up available.
Typical Costs in China
Prices are reference ranges; final quotes come from the hospital after case review.
Top Hospitals for Colorectal Cancer
Frequently Asked Questions
Which hospitals are best for colorectal cancer in China?
The Cancer Hospital of CAMS (Beijing) is recorded in our directory as first in oncology nationally, and Sun Yat-sen University Cancer Center (Guangzhou) is recorded in the national top three. Fudan University Shanghai Cancer Center has one of the country's strongest colorectal surgery departments, and Zhongshan Hospital in Shanghai is recorded as a leading digestive-disease centre and a top-five oncology hospital. All are recorded as offering international patient services.
Can rectal cancer be treated without a permanent stoma in China?
Sometimes. Whether the sphincter can be preserved depends on tumour height, how the tumour responded to chemoradiotherapy, and pelvic anatomy — assessed from your MRI and endoscopy by a high-volume centre. Where preservation is not possible, a permanent stoma (abdominoperineal resection) may be required for a curative operation. The decision is made per patient after specialist review, and it is the question most worth asking your surgeon directly.
Does chemotherapy come before surgery for colorectal cancer?
It depends on the site. Colon cancer is usually treated with surgery first, followed by chemotherapy if the stage warrants it. Locally advanced rectal cancer commonly receives chemotherapy and radiotherapy before surgery, which is called neoadjuvant treatment — it can shrink the tumour and make a sphincter-preserving operation more likely. The order is set from your staging scans, not from hospital preference.
Which tests decide which drugs I am offered?
Molecular testing on the tumour, and it matters more than most patients expect. MMR/MSI status tells you whether immunotherapy is likely to work — MSI-high or dMMR tumours respond to it. RAS and BRAF mutation testing tells you whether an anti-EGFR agent such as cetuximab is worth using, because it only helps RAS wild-type tumours. The standard chemotherapy backbones are FOLFOX or FOLFIRI, with bevacizumab a common addition. Without these results, a drug plan is guesswork.
How much does colorectal cancer treatment cost in China?
Our published reference ranges: colorectal cancer surgery runs $12,000–$20,000 in China against $60,000–$100,000 in the US, and a full treatment course runs $25,000–$50,000 against $120,000–$200,000. The final quote depends on the site of the tumour, the stage, and which drugs the regimen uses.
How long does treatment take in China?
Records and imaging can be reviewed before you travel, and a plan is typically agreed within two to four weeks. A colectomy involves roughly a week in hospital, and a surgical episode including recovery is usually planned as three to four weeks in China. If your plan starts with chemoradiotherapy, that course runs about five to six weeks before surgery, and chemotherapy cycles commonly run every two to three weeks.
How this directory is checked
57 Grade 3A hospitals across 13 cities. 20 score 0.9 or above on our verification scale, and 5 were cross-checked against three or more independent sources. Every listing was last verified between 2026-04-06 and 2026-10-13.
Considering treatment for Colorectal Cancer?
Tell us your diagnosis, scans and timing. We'll match you with the right Grade 3A hospital, compare likely costs, and outline the next practical step — free, no commitment.
Start Free Case Review →